JP4842507B2 - 抗インフルエンザウイルス活性化物質 - Google Patents
抗インフルエンザウイルス活性化物質 Download PDFInfo
- Publication number
- JP4842507B2 JP4842507B2 JP2003389739A JP2003389739A JP4842507B2 JP 4842507 B2 JP4842507 B2 JP 4842507B2 JP 2003389739 A JP2003389739 A JP 2003389739A JP 2003389739 A JP2003389739 A JP 2003389739A JP 4842507 B2 JP4842507 B2 JP 4842507B2
- Authority
- JP
- Japan
- Prior art keywords
- maitake
- extract
- influenza virus
- water
- dried
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 241000700605 Viruses Species 0.000 title claims description 31
- 206010022000 influenza Diseases 0.000 title claims description 26
- 239000012190 activator Substances 0.000 title description 11
- 240000001080 Grifola frondosa Species 0.000 claims description 39
- 235000007710 Grifola frondosa Nutrition 0.000 claims description 39
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 33
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 23
- 239000000284 extract Substances 0.000 claims description 21
- 239000007788 liquid Substances 0.000 claims description 17
- 239000000126 substance Substances 0.000 claims description 10
- 238000001556 precipitation Methods 0.000 claims description 8
- 239000003795 chemical substances by application Substances 0.000 claims 3
- 229940124393 anti-influenza virus drug Drugs 0.000 claims 1
- 238000002156 mixing Methods 0.000 claims 1
- 229940075071 maitake extract Drugs 0.000 description 33
- 210000004027 cell Anatomy 0.000 description 23
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 17
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 17
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 17
- 108020004999 messenger RNA Proteins 0.000 description 13
- 230000000694 effects Effects 0.000 description 11
- 239000000843 powder Substances 0.000 description 10
- 235000013305 food Nutrition 0.000 description 9
- 210000002540 macrophage Anatomy 0.000 description 9
- 241000712461 unidentified influenza virus Species 0.000 description 7
- 230000003247 decreasing effect Effects 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 230000008859 change Effects 0.000 description 5
- 231100000135 cytotoxicity Toxicity 0.000 description 5
- 230000003013 cytotoxicity Effects 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 239000002244 precipitate Substances 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 230000000638 stimulation Effects 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 235000013399 edible fruits Nutrition 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 238000001694 spray drying Methods 0.000 description 4
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 3
- 229920002498 Beta-glucan Polymers 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 208000037797 influenza A Diseases 0.000 description 3
- 229930014626 natural product Natural products 0.000 description 3
- 239000000825 pharmaceutical preparation Substances 0.000 description 3
- 229940127557 pharmaceutical product Drugs 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 230000036962 time dependent Effects 0.000 description 3
- 230000003612 virological effect Effects 0.000 description 3
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- 238000008157 ELISA kit Methods 0.000 description 2
- 241000222684 Grifola Species 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 239000003636 conditioned culture medium Substances 0.000 description 2
- 239000012228 culture supernatant Substances 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 235000013376 functional food Nutrition 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 208000037798 influenza B Diseases 0.000 description 2
- 238000005342 ion exchange Methods 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 210000002345 respiratory system Anatomy 0.000 description 2
- 238000003757 reverse transcription PCR Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 208000030507 AIDS Diseases 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 208000014644 Brain disease Diseases 0.000 description 1
- 241000282465 Canis Species 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 208000032274 Encephalopathy Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- 102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 1
- 244000097863 Grifola umbellata Species 0.000 description 1
- 235000002897 Grifola umbellata Nutrition 0.000 description 1
- 206010053759 Growth retardation Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241001500351 Influenzavirus A Species 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 208000038016 acute inflammation Diseases 0.000 description 1
- 230000006022 acute inflammation Effects 0.000 description 1
- 231100000460 acute oral toxicity Toxicity 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 210000000991 chicken egg Anatomy 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 206010014599 encephalitis Diseases 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000009422 growth inhibiting effect Effects 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229960003971 influenza vaccine Drugs 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 208000013465 muscle pain Diseases 0.000 description 1
- 231100000243 mutagenic effect Toxicity 0.000 description 1
- 230000003505 mutagenic effect Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 239000008239 natural water Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000001223 reverse osmosis Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 238000005201 scrubbing Methods 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 230000006433 tumor necrosis factor production Effects 0.000 description 1
Images
Landscapes
- Medicines Containing Plant Substances (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003389739A JP4842507B2 (ja) | 2003-11-19 | 2003-11-19 | 抗インフルエンザウイルス活性化物質 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003389739A JP4842507B2 (ja) | 2003-11-19 | 2003-11-19 | 抗インフルエンザウイルス活性化物質 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005145934A JP2005145934A (ja) | 2005-06-09 |
| JP2005145934A5 JP2005145934A5 (enExample) | 2006-11-24 |
| JP4842507B2 true JP4842507B2 (ja) | 2011-12-21 |
Family
ID=34696386
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003389739A Expired - Fee Related JP4842507B2 (ja) | 2003-11-19 | 2003-11-19 | 抗インフルエンザウイルス活性化物質 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP4842507B2 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007031665A (ja) * | 2005-07-29 | 2007-02-08 | Yukiguni Maitake Co Ltd | マイタケから抽出した糖―タンパク複合体 |
| JP2008106018A (ja) | 2006-10-27 | 2008-05-08 | Yukiguni Maitake Co Ltd | マイタケ由来の抗インフルエンザウイルス活性を有する物質及びその製造方法 |
| JP2008161109A (ja) | 2006-12-28 | 2008-07-17 | Yukiguni Maitake Co Ltd | 離乳期子豚における疾病予防方法 |
| JP2008161120A (ja) | 2006-12-28 | 2008-07-17 | Yukiguni Maitake Co Ltd | 母豚の飼育方法 |
| JP5882635B2 (ja) * | 2011-08-22 | 2016-03-09 | 株式会社雪国まいたけ | マイタケ由来の高分子α−グルカン |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2905911B2 (ja) * | 1993-09-02 | 1999-06-14 | 株式会社雪国まいたけ | Ａｉｄｓにおけるヘルパーｔ細胞数の減少抑制若しくは増加剤 |
| JP2859843B2 (ja) * | 1996-03-08 | 1999-02-24 | 株式会社雪国まいたけ | マイタケから抽出した抗腫瘍物質 |
| JP3260329B2 (ja) * | 1998-10-20 | 2002-02-25 | 株式会社雪国まいたけ | マイタケ由来の活性酸素消去剤 |
| JP2001172194A (ja) * | 1999-12-17 | 2001-06-26 | Yukiguni Maitake Co Ltd | マイタケ由来のｎｏ産生誘導剤 |
-
2003
- 2003-11-19 JP JP2003389739A patent/JP4842507B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP2005145934A (ja) | 2005-06-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004250445A (ja) | グリケーション阻害剤及びその利用 | |
| JP7756864B2 (ja) | インフルエンザの重症化を抑制するための抗インフルエンザウイルス剤 | |
| CN104131057A (zh) | 一种功能性白芸豆多肽及其制备方法和应用 | |
| CN104337836A (zh) | 一种具有降尿酸功效的柴鱼蛋白水解物制备方法 | |
| JPWO2005077349A1 (ja) | ヒトβディフェンシン産生促進剤 | |
| WO2005007640A1 (ja) | ウィルス感染症の予防または治療用組成物 | |
| JP5594819B2 (ja) | 脂質代謝改善用組成物 | |
| JP4842507B2 (ja) | 抗インフルエンザウイルス活性化物質 | |
| CN109806383A (zh) | 一种鳗鱼肽在制备促进免疫的食品、药品或保健品中的应用 | |
| EP2087899B1 (en) | Grifola frondosa-derived substance having anti-influenza virus activity and method for producing the same | |
| CN111657501A (zh) | 一种具有增强免疫力功能的牡蛎肽虫草菌丝体组合物及其应用 | |
| JP2023026528A (ja) | シアノバクテリア抽出物、その調製方法と利用方法 | |
| JP2021061828A (ja) | ２種以上の生薬抽出物を有効成分として含む免疫力増進用組成物 | |
| JP2023179383A (ja) | アミロイドβによるリン酸化タウタンパク質の増加抑制用の組成物 | |
| KR102326439B1 (ko) | 인삼을 포함하는 항균, 항염, 항바이러스 및 면역 기능 개선용 조성물 | |
| KR101637476B1 (ko) | 청고추 추출물을 유효 성분으로 포함하는 인플라마좀 매개 염증성 질환 및 인플루엔자 바이러스 감염 예방, 개선용 조성물 | |
| CN115581300A (zh) | 一种缓解疲劳增强免疫力的组合物及其制备方法 | |
| JP2011088881A (ja) | 抗インフルエンザウイルス剤並びに当該物質を含有する飲食品若しくは医薬品 | |
| CN104138396B (zh) | 白囊耙齿菌在制备抗疲劳保健品中的用途 | |
| JP6541047B1 (ja) | 経口組成物 | |
| CN118086433B (zh) | 鳕鱼皮活性多肽粉及其用于抗病毒、杀菌的用途 | |
| JP7090864B2 (ja) | 組成物 | |
| KR102716093B1 (ko) | 민물김 추출물 또는 이의 분획물을 유효성분으로 포함하는 염증성 폐질환의 예방 또는 치료용 조성물 | |
| WO2025053239A1 (ja) | 睡眠の質改善剤 | |
| HK40049204A (en) | Composition for improving cognitive function speed |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20061006 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20061006 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100309 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100507 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20100803 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20101028 |
|
| A911 | Transfer of reconsideration by examiner before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20101228 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110405 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110606 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20110913 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20111006 |
|
| R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20141014 Year of fee payment: 3 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313111 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| LAPS | Cancellation because of no payment of annual fees |